(Q71056359)
Statements
Combination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinoma (English)
T Himoto
S Watanabe
M Nishioka
T Maeba
S Tanaka
1 February 1996